|
MechanismDRDs antagonists |
|
Originator Org.- |
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.IT |
First Approval Date13 Aug 2003 |
左舒必利注射液治疗急性呕吐随机、单盲、阳性药平行对照、多中心临床试验
[Translation] A randomized, single-blind, positive-drug parallel-controlled, multicenter clinical trial of levosulpiride injection in the treatment of acute vomiting
以盐酸甲氧氯普胺注射液为对照,评价左舒必利注射液治疗急性呕吐的有效性和安全性。
[Translation] To evaluate the efficacy and safety of levosulpiride injection in the treatment of acute vomiting, using metoclopramide hydrochloride injection as a control.
左舒必利注射液在中国健康人体中的单中心、随机、开放的单次、多次人体药代动力学试验
[Translation] A single-center, randomized, open-label, single-dose and multiple-dose pharmacokinetic study of levosulpiride injection in healthy Chinese subjects
健康受试者进行左舒必利注射液的药代动力学试验,测定主要成分左舒必利的经时血药浓度,估算其主要药代动力学参数,了解左舒必利注射液在健康人体内的吸收、分布、消除、代谢规律,为制定左舒必利注射液II期临床试验方案提供试验依据,为临床用药的给药剂量提供依据。
[Translation] A pharmacokinetic study of levosulpiride injection was conducted on healthy subjects to determine the time-dependent blood concentration of the main ingredient levosulpiride, estimate its main pharmacokinetic parameters, and understand the absorption, distribution, elimination, and metabolism of levosulpiride injection in healthy humans, so as to provide an experimental basis for the formulation of the Phase II clinical trial plan for levosulpiride injection and provide a basis for the dosage of clinical medication.
100 Clinical Results associated with Hainan Tianya Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Hainan Tianya Pharmaceutical Co., Ltd.
100 Deals associated with Hainan Tianya Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Hainan Tianya Pharmaceutical Co., Ltd.